1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Exploratory analysis of perfusion patterns for predicting time-to-progression in patients with glioblastoma
CEL (No. of voxels) Time-to-Progression
HR^{^a} 95% CI P Value
High angiogenic tumor (1) 0.13 0.01–4.59 .25
High angiogenic tumor (2) 4.74 0.01–231.7 .62
Low angiogenic/cellular tumor 0.99 0.10 –9.91 .99
Perinecrotic lesion 22.3 0.44–111.30 .11
CEL (%) 
 High angiogenic tumor (1) 0.71 0.20–2.51 .59
 High angiogenic tumor (2) 0.65 0.21–2.04 .46
 Low angiogenic/cellular tumor 2.14 0.33–14.03 .42
 Perinecrotic lesion 2.67 0.52–13.63 .24
NEL (No. of voxels) 
 High angiogenic tumor (3) 0.95 0.29–3.06 .93
 Low angiogenic/cellular tumor 2.18 1.01–12.57 .047
 Infiltrated edema 1.88 1.35–2.78 .009
 Vasogenic edema 1.04 0.71–1.52 .84
NEL 
 High angiogenic tumor (3) 0.25 0.21–5.31 .37
 Low angiogenic/cellular tumor 0.41 0.08–1.99 .27
 Infiltrated edema 2.14 0.40–11.35 .37
 Vasogenic edema 4.20 0.52–33.98 .18
↵a HRs reported here indicate the relative change in hazard that a 1-U (10,000 voxels for the number of voxels and 1% for percentage) increase in each imaging parameter incurs.